VSHP-Dynamics in the Biosimilar Landscape: Recent and Upcoming Changes

Speaker:
Mark Maas, PharmD, BCPS
Clinical Pharmacy Specialist, Drug Information and Policy
Department of Pharmacy Services, VCU Health System

Presentation Objectives for Pharmacists:
1. Define biosimilar, interchangeable, and unbranded biologic.
2. Determine the optimal infliximab biosimilar for your institution.
3. Prepare your institution for the marketing of adalimumab biosimilars.
Presentation Objectives for Pharmacy Technicians:
1. Define biosimilar, interchangeable, and unbranded biologic.
2. List the steps taken to assess infliximab biosimilars at your institution.
3. Prepare your institution for the marketing of adalimumab biosimilars.

01:00:00